Tuesday, October 4, 2022
More

    Home Health CORBEVAX Booster Approved For 18 Yrs And Above

    CORBEVAX Booster Approved For 18 Yrs And Above

    New Delhi [India]: The Central government has approved Biological E’s Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday.

    Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological E’s CORBEVAX as a heterologous booster for adults above 18 yrs old.

    On June 4, this year Biological E. Limited (BE), a Hyderabad-based pharmaceutical and vaccines company announced that its CORBEVAX COVID-19 vaccine has been approved by the Drug Controller General of India (DCGI) as a heterologous booster dose after 6 months of administration of primary jabs of Covaxin or Covishield vaccines for restricted use in the emergency situation for the individuals aged 18 years and above.

    “BE’s CORBEVAX is the first such vaccine in India to be approved as a heterologous COVID-19 booster. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation and deliberations with the Subject Experts Committee, granted their approval for administering the Corbevax vaccine as a heterologous booster dose to people who have already taken two doses of either Covishield or Covaxin,” an official statement from BE read.

    “BE’s clinical trial data showed that Corbevax booster dose provided significant enhancement in immune response and excellent safety profile required for an effective booster,” it added.

    Mahima Datla, Managing Director, Biological E. Limited, said, “We are very happy with this approval, which will address the need for COVID-19 booster doses in India. We have crossed yet-another milestone in our COVID-19 vaccination journey. This approval reflects that once again sustained world-class safety standards and high immunogenicity of Corbevax.”

    “BE has conducted a multicentre Phase III placebo-controlled heterologous booster clinical trial in 416 subjects from 18 to 80 years of age who were previously vaccinated with two doses of either COVISHIELD or COVAXIN at least 6 months prior to the administration of Corbevax as a booster dose,” the statement read further.

    “The booster dose of Corbevax increased the neutralizing antibody titers in the Covishield and Covaxin groups significantly when compared to the placebo,” it added.

    So far, India’s Cumulative COVID-19 vaccination Coverage has exceeded 207.03 Crore (2,07,03,71,204) till 7 am on August 10. New Delhi [India], August 10 (ANI): The Central government has approved Biological E’s Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday. On Tuesday, ANI had reported that Corbevax booster for heterologous first has been approved by the Centre.
    Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological E’s CORBEVAX as a heterologous booster for adults above 18 yrs old.

    On June 4, this year Biological E. Limited (BE), a Hyderabad-based pharmaceutical and vaccines company announced that its CORBEVAX COVID-19 vaccine has been approved by the Drug Controller General of India (DCGI) as a heterologous booster dose after 6 months of administration of primary jabs of Covaxin or Covishield vaccines for restricted use in the emergency situation for the individuals aged 18 years and above.

    “BE’s CORBEVAX is the first such vaccine in India to be approved as a heterologous COVID-19 booster. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation and deliberations with the Subject Experts Committee, granted their approval for administering the Corbevax vaccine as a heterologous booster dose to people who have already taken two doses of either Covishield or Covaxin,” an official statement from BE read.

    “BE’s clinical trial data showed that Corbevax booster dose provided significant enhancement in immune response and excellent safety profile required for an effective booster,” it added.

    Mahima Datla, Managing Director, Biological E. Limited, said, “We are very happy with this approval, which will address the need for COVID-19 booster doses in India. We have crossed yet-another milestone in our COVID-19 vaccination journey. This approval reflects that once again sustained world-class safety standards and high immunogenicity of Corbevax.”

    “BE has conducted a multicentre Phase III placebo-controlled heterologous booster clinical trial in 416 subjects from 18 to 80 years of age who were previously vaccinated with two doses of either COVISHIELD or COVAXIN at least 6 months prior to the administration of Corbevax as a booster dose,” the statement read further.

    “The booster dose of Corbevax increased the neutralizing antibody titers in the Covishield and Covaxin groups significantly when compared to the placebo,” it added.
    So far, India’s Cumulative COVID-19 vaccination Coverage has exceeded 207.03 Crore (2,07,03,71,204) till 7 am on August 10. 

    RELATED ARTICLES

    Uttarakhand Avalanche: 8 Mountaineers Rescued, Casualties feared

    Eight of the 29 trainee mountaineers, who were trapped in the Uattarkhand avalanche on Tuesday, have been rescued and taken to the Indo-Tibetan Border Police (ITBP) Hospital for treatment, the ITBP said. ...Tap to read more

    Former Maha Minister Anil Deshmukh Gets Bail, Order Then Stayed On ED Appeal

    The Bombay High Court on Tuesday granted bail to former Maharashtra minister Anil Deshmukh in a money laundering case with a surety amount of Rs 1 lakh. ....Tap to read more

    SC: Rs 2 Crore Compensation Granted To Dependents Of Motor Accident Victim

    The Supreme Court granted compensation of over Rs 2 crore to the dependents of a motor accident victim and set aside the Madras High Court order which ordered to grant Rs 57 lakh to the deceased's family. ....Tap to read more

    Most Popular

    Uttarakhand Avalanche: 8 Mountaineers Rescued, Casualties feared

    Eight of the 29 trainee mountaineers, who were trapped in the Uattarkhand avalanche on Tuesday, have been rescued and taken to the Indo-Tibetan Border Police (ITBP) Hospital for treatment, the ITBP said. ...Tap to read more

    Former Maha Minister Anil Deshmukh Gets Bail, Order Then Stayed On ED Appeal

    The Bombay High Court on Tuesday granted bail to former Maharashtra minister Anil Deshmukh in a money laundering case with a surety amount of Rs 1 lakh. ....Tap to read more

    SC: Rs 2 Crore Compensation Granted To Dependents Of Motor Accident Victim

    The Supreme Court granted compensation of over Rs 2 crore to the dependents of a motor accident victim and set aside the Madras High Court order which ordered to grant Rs 57 lakh to the deceased's family. ....Tap to read more

    Alain Aspect, John F. Clauser & Anton Zeilinger Awarded Nobel Prize In Physics

    The Royal Swedish Academy of Sciences on Tuesday awarded the 2022 Nobel Prize in Physics to Alain Aspect, John F Clauser and Anton Zeilinger for groundbreaking experiments using entangled quantum states that cleared the way for new technology based upon quantum information. ....Tap to read more

    Recent Comments